6 completed. 5 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow BioSante Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer degarelix acetate, Cyclophosphamide, GVAX - Prostate Cancer Adenocarcinoma in Situ | Phase 1 / Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 29 | 2013-01-18 | 2019-03-28 |
| Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) transdermal testosterone gel 1%, placebo gel - Hypoactive Sexual Desire Disorder | Phase 3 | Completed | BioSante Pharmaceuticals | 626 | 2010-10-01 | 2013-01-10 |
| Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women testosterone gel, placebo gel - Hypoactive Sexual Desire Disorder | Phase 3 | Completed | BioSante Pharmaceuticals | 575 | 2008-03-01 | 2013-01-10 |
| Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women testosterone gel, placebo gel - Hypoactive Sexual Desire Disorder | Phase 3 | Completed | BioSante Pharmaceuticals | 3656 | 2008-01-01 | 2021-10-29 |
| Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women testosterone gel, placebo gel - Hypoactive Sexual Desire Disorder | Phase 3 | Completed | BioSante Pharmaceuticals | 597 | 2006-12-01 | 2013-01-10 |
| Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms estradiol gel - Hot Flashes | Phase 3 | Completed | BioSante Pharmaceuticals | 431 | 2003-09-01 | 2006-10-24 |
Sexual Dysfunctions, Psychological (4) · Breast Neoplasms (1) · Hot Flashes (1)
Testosterone Propionate (3) · Cyclophosphamide (1) · acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (1)
United States (5) · Canada (4)
Michael C Snabes, MD, PhD (4) · Emmanual Antonarakis, M.D (1)